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Diabetes mellitus is affecting many people throughout the world. Diabetic retinopathy 
(DR) is a long-term complication of diabetes associated with impaired vision. If left untreated DR 
may eventually lead to blindness. DR is caused by a damage to the small blood vessels in the 
retina. According to the American Academy of Ophthalmology, 5-10 % of the diabetic patients 
with normal retinal exams will develop DR within a year of their last retinal exam.  The diabetic 
individuals who currently have DR are similarly susceptible to developing more severe 
retinopathy. Unfortunately many individuals with diabetes fail to receive education about 
maintaining glycemic control, medication management and recommended frequency of tests to 
monitor diabetic complications such as DR. Several studies have shown that the disease 
management services are effective in improving the quality of care for persons with diabetes. An 
increasing number of disease management programs utilize pharmacists to assist in the disease 
management of diabetic individuals. For this clinical study we evaluated the effect of pharmacist-
managed CVRRs on the development of DR in over 100 diabetic individuals. The patient records 
were assessed for demographics (e.g. age, sex etc.), metabolic parameters (lipid profile, HbA1c) 
along with number of pharmacist appointments and ophthalmology records. We observed that 95% 
of the patients who have had pharmacist intervention have been able to keep their retinopathy from 
getting worse or have improved it. Our studies suggest that there is a correlation supporting the 
theory that pharmacist intervention helps manage or reduce the severity of DR. Further studies can 
be conducted in the area to find potential ways to help decrease the severity of DR in patients with 
diabetes and maybe even prevent diabetic patients from developing DR. 
